Table 3.
Independent predictors of PERT efficacy in chronic pancreatitis patients in the North American Pancreatitis Study 2 based on multivariate analyses.
| Variable | Odds ratio | 95% Confidence Interval |
|---|---|---|
| Male Gender vs. female | 0.83 | 0.53 – 1.29 |
|
| ||
| Age | ||
| <35 vs. 35-44 | 1.16 | 0.59 – 2.31 |
| 45-64 vs. 35-44 | 1.51 | 0.85 -2.69 |
| 65+ vs. 35-44 | 1.67 | 0.76-3.66 |
|
| ||
| Exocrine Insufficiency | 2.16 | 1.36 – 3.42 |
PERT – pancreatic enzyme replacement therapy
Gender and age were forced into the model. Other variables entered into the model were frequency of pain, severity of pain, endocrine insufficiency and race